Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02952729
Recruitment Status : Completed
First Posted : November 2, 2016
Last Update Posted : February 24, 2021
Information provided by (Responsible Party):
Mersana Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 28, 2019
Actual Study Completion Date : January 28, 2019